Results 31 to 40 of about 2,075,366 (204)

Clinical Importance of Left Atrial Infiltration in Cardiac Transthyretin Amyloidosis [PDF]

, 2022
Objectives: The aim of this study was to characterize left atrial (LA) pathology in explanted hearts with transthyretin amyloid cardiomyopathy (ATTR-CM); LA mechanics using echocardiographic speckle-tracking in a large cohort of patients with ATTR-CM ...
Bandera, Francesco, Brown, James, Cappelli, Francesco, Chacko, Liza, Fontana, Marianna, Ganesananthan, Sharmananthan, Gilbertson, Janet A, Gillmore, Julian D, Guazzi, Marco, Hawkins, Philip N, Knight, Daniel, Lachmann, Helen, Lane, Thirusha, Leone, Ornella, Martinez-Naharro, Ana, Martone, Raffaele, Moon, James, Patel, Rishi, Petrie, Aviva, Ponticos, Markella, Potena, Luciano, Quarta, Cristina, Rapezzi, Claudio, Razvi, Yousuf, Rowczenio, Dorota, Wechelakar, Ashutosh, Whelan, Carol   +26 more
core   +1 more source

Detection of transthyretin amyloid cardiomyopathy by automated data extraction from electronic health records

ESC Heart Failure, 2023
Aims Transthyretin amyloid cardiomyopathy (ATTR‐CM), a progressive and fatal cardiomyopathy, is frequently misdiagnosed or entails diagnostic delays, hindering patients from timely treatment.
Ana Moya, Clara L. Oeste, Monika Beles, Sofie Verstreken, Riet Dierckx, Ward Heggermont, Jozef Bartunek, Eline Bogaerts, Imke Masuy, Dries Hens, Dario Bertolone, Marc Vanderheyden   +11 more
doaj   +1 more source

Frequency of hereditary transthyretin amyloidosis among elderly patients with transthyretin cardiomyopathy [PDF]

, 2022
Transthyretin amyloid cardiomyopathy (ATTR-CM) is increasingly recognized as a cause of heart failure in the elderly. Although wild-type transthyretin amyloidosis is the most frequent form of ATTR-CM found in the elderly, hereditary transthyretin ...
Briceño, Ana, Cabrera, Eva, Cobo Marcos, Marta, Dominguez, Fernando, Frutos, Fernando de, García Pavía, Pablo, Gonzalez Vioque, Emiliano, Gonzalez-Lopez, Esther, Lara Pezzi, Enrique, Maestro Benedicto, Alba, Mora, Nerea, Pomares, Antonia, Segovia Cubero, Javier, Vela, Paula   +13 more
core   +4 more sources

Progression of echocardiographic parameters and prognosis in transthyretin cardiac amyloidosis [PDF]

, 2022
Aims: Transthyretin amyloid cardiomyopathy (ATTR-CM) is an increasingly diagnosed disease. Echocardiography is widely utilized, but studies to confirm the value of echocardiography for tracking changes over time are not available.
Adam Ioannou, Aldostefano Porcari, Ana Martinez-Naharro, Ashutosh Wechelakar, Aviva Petrie, Beatrice Dal Passo, Candida C. Quarta, Carol Whelan, Charlotte Manisty, Claudio Rapezzi, Daniel Knight, Dorota Rowczenio, Francesco Bandera, Helen Lachmann, James Brown, James Moon, Janet A. Gilbertson, Jonathan Lazari, Julian D. Gillmore, Liza Chacko, Lodovico Buonamici, Lucia Venneri, Luciano Potena, Marianna Fontana, Mattia Riefolo, Nina Karia, Ornella Leone, Philip N. Hawkins, Richard P. Steeds, Rishi Patel, William E. Moody, Yousuf Razvi   +31 more
core   +1 more source

Nationwide prevalence and characteristics of transthyretin amyloid cardiomyopathy in Sweden

Open Heart, 2021
Objective Transthyretin amyloid cardiomyopathy (ATTR-CM) is a rare, progressive and fatal condition caused by deposition of transthyretin amyloid fibrils in the heart.
J Gustav Smith, Finn Gustafsson, Johanna Kuusisto, Einar Gude, Rosa Elisabeth Lauppe, Johan Liseth Hansen, Christian Gerdesköld, Mark H Rozenbaum, Anne Mette Strand, Merja Vakevainen   +9 more
doaj   +1 more source

Healthcare resource use of patients with transthyretin amyloid cardiomyopathy

ESC Heart Failure, 2022
Aims Transthyretin amyloid cardiomyopathy (ATTR‐CM) is the cardiac manifestation of transthyretin amyloidosis (ATTR). The aim of this study was to estimate healthcare resource use for ATTR‐CM patients compared with heart failure (HF) patients, in Denmark,
Rosa Lauppe, Johan Liseth Hansen, Anna Fornwall, Katarina Johansson, Mark H. Rozenbaum, Anne Mette Strand, Merja Vakevainen, Johanna Kuusisto, Einar Gude, J. Gustav Smith, Finn Gustafsson   +10 more
doaj   +1 more source

Summation of Precordial R Wave Amplitudes, a Clinical Parameter for Detecting Early TTR Amyloidosis Cardiac Involvement

Journal of Cardiovascular Development and Disease, 2022
There have been several reports on the identification of the stage of transthyretin amyloid cardiomyopathy (ATTR-CM); however, a staging system for ATTR-CM has not yet been established.
Yoshitaka Isotani, Eisuke Amiya, Junichi Ishida, Issei Komuro   +3 more
doaj   +1 more source

Assessment and Management of Older Patients With Transthyretin Amyloidosis Cardiomyopathy: Geriatric Cardiology, Frailty Assessment and Beyond

Frontiers in Cardiovascular Medicine, 2022
Transthyretin amyloidosis cardiomyopathy (ATTR-CM) is commonly diagnosed in older adults, in particular the wild-type (ATTRwt), which is regarded as an age-related disease.
Biobelemoye Irabor, Jacqueline M. McMillan, Jacqueline M. McMillan, Nowell M. Fine, Nowell M. Fine   +4 more
doaj   +1 more source

Prevalence of transthyretin amyloidosis among heart failure patients with preserved ejection fraction in Japan

ESC Heart Failure, 2023
Aims Heart failure with preserved ejection fraction (HFpEF), which is caused by wide various conditions, has become a major public health problem. Transthyretin amyloid cardiomyopathy (ATTR‐CM), which is thought to be an underdiagnosed disease, can cause
Takanori Naito, Kazufumi Nakamura, Yukio Abe, Hiroyuki Watanabe, Satoru Sakuragi, Yusuke Katayama, Hajime Kihara, Atsutaka Okizaki, Yusuke Kawai, Masaki Yoshikawa, Atsushi Takaishi, Hideki Fujio, Hiroaki Otsuka, Soichiro Ogura, Hiroshi Ito, ATTR‐HFpEF registry investigators   +15 more
doaj   +1 more source

Utility of Genetic Testing in Patients with Transthyretin Amyloid Cardiomyopathy: A Brief Review

Biomedicines, 2023
Transthyretin amyloid cardiomyopathy (ATTR-CM) is an increasingly diagnosed condition. Although wild-type transthyretin amyloidosis (ATTRwt) is the most common ATTR-CM, hereditary transthyretin amyloidosis (ATTRv) may also occur.
Ana-Maria Merino-Merino, Jorge Labrador-Gomez, Ester Sanchez-Corral, Pedro-David Delgado-Lopez, Jose-Angel Perez-Rivera   +4 more
doaj   +1 more source